We’ve moved out of our offices to enable the demolition of the Southside building in Victoria street. We are currently in interim offices and our new address is BioIndustry Association, LABs, Victoria House, Bloomsbury Way, London, WC1B 4DA. We say goodbye to Southside after over 11 years... Read on for an update on the Conservative Party and Labour Party conferences, Board Elections and TechBio UK Conference.
Following the announcement about the BioIndustry Association (BIA) reaching a new milestone of 500 member companies earlier this week, we spoke with Darius Hughes, UK General Manager at Moderna to learn more about the mRNA global player and his intentions behind joining the trade association’s membership.
Chancellor highlights the globally leading role of the life science sector in Friday’s mini-budget and launches a new UK TIBI-like investment initiative for innovative firm financing and sad news about former BIA CEO Aisling Burnand. Read on for updates on the party conferences, BIA events, Annual General Meeting and Board Elections plus our new office location.
Ahead of the 19th annual bioProcessUK conference (15-17 November, Edinburgh), we spoke to Simon Simpkins PhD, VP, Head of Operational Strategy at Oxford Biomedica about the company's digital future, where the foundational concept of good data management underpins all aspirations. But how do you build that integrated vision and keep the business running at the same time?
Making his first statement as Chancellor of the Exchequer today, Kwasi Kwarteng said the UK enjoys an “unbound entrepreneurial culture” and “immense global presence in sectors like… life sciences”, but that in many areas of the economy, he said, tax and regulation is holding back growth. Read more about key announcements for life sciences in the new Plan for Growth and three priority areas for expanding the supply side of the economy.
Yesterday the United Kingdom paid its final respects and laid to rest Queen Elizabeth II in an incredible state funeral in central London, a ceremony of which we haven’t seen in a generation and was marked and watched across the entire world. As the chapter closes on the 70 years of the Elizabethan age, I have reflected on the innovations and changes we have seen in the sector over that period and look forward to the advances the sector will make under our new King.
All of us at the BioIndustry Association (BIA) have been shocked and saddened by the death of the Queen. I shared a reflection on her life from a life science industry perspective on Friday. We are also posting official guidance from the UK Government on what to do during this extraordinary period for BIA members. Next Monday will see the State Funeral and a UK Bank Holiday – BIA will be closed on the day and next week’s Newscast will be on Tuesday. For the rest of this week, we continue to work as normal.
We spoke with Jelle Penders, CEO, CTO and Founder of SPARTA Biodiscovery, an Imperial College London spin-out commercialising the SPARTA® (Single Particle Automated Raman Trapping Analysis) technology.
Queen Elizabeth II was a stateswoman, not a scientist. But throughout her reign, she championed and embraced life science innovation. She made sure our society thought through and got comfortable with, the implications of what became scientifically possible.